Hyper-phosphorylation and somato-dendritic accumulation of tau, as well as a decrease in PP2A expression, are observed in the brain of patients with AD, suggesting that a reduction of PP2A activity could possibly be involved in the pathogenesis in AD [32]. The gene discussed is MAPT; the disease is Alzheimer disease.